The sale of shares in WuXi XDC, a developer of antibody-drug conjugates, came a day before the U.S. president shocked markets with his tariff plan on April 2 The impact of any further punitive ...

Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...

Wuxi’s recent history might be all about its industrial revolution, but exploring the area’s timeless lakes, caves and mountains is the real pull for visitors. Wuxi is a city built on industry ...